ASLAN Pharmaceuticals Statistics

Total Valuation

LON:0K1R has a market cap or net worth of GBP 1.09 billion. The enterprise value is 825.81 million.

Market Cap	1.09B
Enterprise Value	825.81M

Important Dates

The last earnings date was Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	81.66M
Shares Outstanding	n/a
Shares Change (YoY)	+41.68%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	67.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4,877.43
PB Ratio	2.89
P/TBV Ratio	4.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.10
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.65

Financial Position

The company has a current ratio of 11.01, with a Debt / Equity ratio of 0.04.

Current Ratio	11.01
Quick Ratio	10.71
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.07
Interest Coverage	-125.45

Financial Efficiency

Return on equity (ROE) is -65.88% and return on invested capital (ROIC) is -42.61%.

Return on Equity (ROE)	-65.88%
Return on Assets (ROA)	-39.77%
Return on Invested Capital (ROIC)	-42.61%
Return on Capital Employed (ROCE)	-70.14%
Revenue Per Employee	1,557
Profits Per Employee	-1.41M
Employee Count	143
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.10% in the last 52 weeks. The beta is 0.48, so LON:0K1R's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	+7.10%
50-Day Moving Average	16.03
200-Day Moving Average	17.04
Relative Strength Index (RSI)	53.50
Average Volume (20 Days)	264

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	15.67

Income Statement

In the last 12 months, LON:0K1R had revenue of GBP 222,620 and -201.26 million in losses. Loss per share was -2.60.

Revenue	222,620
Gross Profit	-222.09M
Operating Income	-271.22M
Pretax Income	-251.13M
Net Income	-201.26M
EBITDA	-270.87M
EBIT	-271.22M
Loss Per Share	-2.60

Full Income Statement

Balance Sheet

The company has 411.19 million in cash and 16.85 million in debt, giving a net cash position of 394.35 million.

Cash & Cash Equivalents	411.19M
Total Debt	16.85M
Net Cash	394.35M
Net Cash Per Share	n/a
Equity (Book Value)	376.02M
Book Value Per Share	2.92
Working Capital	384.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -225.59 million and capital expenditures -390,497, giving a free cash flow of -225.98 million.

Operating Cash Flow	-225.59M
Capital Expenditures	-390,497
Free Cash Flow	-225.98M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-121,830.87%
Pretax Margin	-112,806.63%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0K1R does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.68%
Shareholder Yield	n/a
Earnings Yield	-18.54%
FCF Yield	-20.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 13, 2020. It was a reverse split with a ratio of 0.0666666667.

Last Split Date	Nov 13, 2020
Split Type	Reverse
Split Ratio	0.0666666667

Scores

LON:0K1R has an Altman Z-Score of 7.89 and a Piotroski F-Score of 1.

Altman Z-Score	7.89
Piotroski F-Score	1